Table 1 gH1-specific cytokine responses following vaccination with gH1-Qbeta.

From: Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

Cytokine/Chemokine

Non-adjuvanted

Adjuvanted

Day 0

Day 21

Day 42

Day 0

Day 21

Day 42

Proinflammatory

   IFN-γ

34.18

137.38

138.55

37.76

257.89

211.80

   IL-2

4.91

0.80

0.71

4.73

0.01

0.01

   TNF-β (LTα)

0.01

0.01

0.01

0.01

0.01

0.01

   IL-6

4996.66

15438.32

4752.26

5260.17

15465.00

4911.00

   TNF-α

161.17

165.73

155.83

200.76

212.66

190.88

   MIP-3α (CCL20)

143.70

174.80

84.49

141.99

140.32

100.57

Th2

   IL-4

0.01

0.01

0.01

0.01

0.01

0.01

   IL-5

1.63

5.79

5.58

1.59

5.28

5.39

   IL-13

34.41

73.18

58.48

31.72

90.44

68.04

Th17

   IL-17A

8.42

30.64

33.24

8.76

20.88

13.25

   IL-17F

0.11

0.40

0.25

0.08

0.40

0.28

Th9

   IL-9

0.54

2.05

2.48

0.07

3.25

5.39

   Th22

   IL-22

0.01

0.01

0.01

0.01

0.01

0.01

Treg

   IL-10

17.95

23.09

17.78

16.28

23.27

19.83

Tfh

   IL-21

0.01

0.01

0.01

0.01

0.61

0.47

  1. Data are median gH1-specific cytokine responses, pg/ml, measured by 15-plex assay in supernatants from PBMC cultures that were stimulated with peptide libraries specific for gH1 for 8 days. Boldface and underlined text represents values for which there is statistical evidence of higher median values compared with median values at baseline. IL-2 in the adjuvanted group possessed statistically lower median values compared with median values at baseline. In the non-adjuvanted group between one and two doses of vaccine statistically lower median values were observed for MIP-3α.